Harrow, Inc. (HROW)
39.00
+2.04
(+5.50%)
USD |
NASDAQ |
Sep 02, 16:00
39.00
0.00 (0.00%)
After-Hours: 17:06
Harrow Research and Development Expense (TTM) : 20.56M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.56M |
| March 31, 2026 | 15.36M |
| December 31, 2025 | 12.49M |
| September 30, 2025 | 13.97M |
| June 30, 2025 | 12.92M |
| March 31, 2025 | 13.11M |
| December 31, 2024 | 12.23M |
| September 30, 2024 | 10.81M |
| June 30, 2024 | 9.959M |
| March 31, 2024 | 8.067M |
| December 31, 2023 | 6.652M |
| September 30, 2023 | 4.019M |
| June 30, 2023 | 3.373M |
| March 31, 2023 | 3.126M |
| December 31, 2022 | 3.05M |
| September 30, 2022 | 6.39M |
| June 30, 2022 | 11.74M |
| March 31, 2022 | 11.25M |
| December 31, 2021 | 11.18M |
| September 30, 2021 | 7.733M |
| June 30, 2021 | 2.278M |
| March 31, 2021 | 2.602M |
| December 31, 2020 | 2.413M |
| September 30, 2020 | 2.246M |
| June 30, 2020 | 2.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.081M |
| December 31, 2019 | 2.083M |
| September 30, 2019 | 2.092M |
| June 30, 2019 | 1.881M |
| March 31, 2019 | 1.143M |
| December 31, 2018 | 0.825M |
| September 30, 2018 | 0.481M |
| June 30, 2018 | 0.311M |
| March 31, 2018 | 0.34M |
| December 31, 2017 | 0.413M |
| September 30, 2017 | 0.925M |
| June 30, 2017 | 0.878M |
| March 31, 2017 | 0.853M |
| December 31, 2016 | 0.739M |
| September 30, 2016 | 0.171M |
| June 30, 2016 | 0.248M |
| March 31, 2016 | 0.197M |
| December 31, 2015 | 0.332M |
| September 30, 2015 | 0.3698M |
| June 30, 2015 | 0.3469M |
| March 31, 2015 | 0.3575M |
| December 31, 2014 | 0.2367M |
| September 30, 2014 | 0.18M |
| June 30, 2014 | 0.5794M |
| March 31, 2014 | 1.221M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Viatris, Inc. | 995.00M |
| Zevra Therapeutics, Inc. | 14.83M |
| Indivior Pharmaceuticals, Inc. | 53.00M |
| Liquidia Corp. | 54.95M |
| 60 Degrees Pharmaceuticals, Inc. | 2.329M |